BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 21548194)

  • 21. [Lung cancer].
    Komagata H; Yoneda S
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1609-13. PubMed ID: 15508459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process?
    Ebert W; Muley T; Drings P
    Anticancer Res; 1996; 16(4B):2161-8. PubMed ID: 8694537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum tumor markers for primary lung carcinoma].
    Watanabe R; Takiguchi Y; Kuriyama T
    Nihon Rinsho; 2000 May; 58(5):1070-3. PubMed ID: 10824551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biological markers in lung cancer].
    Nikliński J; Furman M
    Pneumonol Alergol Pol; 1991; 59(5-6):253-9. PubMed ID: 1668877
    [No Abstract]   [Full Text] [Related]  

  • 25. [Value of tumor markers in monitoring of cytotoxic treatment of non-small cell lung cancer].
    Załeska M
    Pneumonol Alergol Pol; 2003; 71(7-8):359-64. PubMed ID: 15052970
    [No Abstract]   [Full Text] [Related]  

  • 26. Biomarkers along the continuum of care in lung cancer.
    Holdenrieder S
    Scand J Clin Lab Invest Suppl; 2016; 245():S40-5. PubMed ID: 27542002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical tumour markers in lung cancer.
    Niklinski J; Furman M
    Eur J Cancer Prev; 1995 Apr; 4(2):129-38. PubMed ID: 7539317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical applications of serum markers for lung cancer.
    Ferrigno D; Buccheri G
    Respir Med; 1995 Oct; 89(9):587-97. PubMed ID: 7494910
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cytokeratins - tissue and biochemical markers of non-small cell lung cancer].
    Szturmowicz M
    Pneumonol Alergol Pol; 2007; 75(4):315-6. PubMed ID: 18080979
    [No Abstract]   [Full Text] [Related]  

  • 30. Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma.
    Gao W; Liu L; Lu X; Shu Y
    Clin Lung Cancer; 2011 Jan; 12(1):14-7. PubMed ID: 21273174
    [No Abstract]   [Full Text] [Related]  

  • 31. Recent advances in biosensor for detection of lung cancer biomarkers.
    Yang G; Xiao Z; Tang C; Deng Y; Huang H; He Z
    Biosens Bioelectron; 2019 Sep; 141():111416. PubMed ID: 31279179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update.
    Anglim PP; Alonzo TA; Laird-Offringa IA
    Mol Cancer; 2008 Oct; 7():81. PubMed ID: 18947422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Present status of serum tumor markers in diagnosis, prognosis, and evaluation of therapy.
    Cohn SL; Lincoln ST; Rosen ST
    Cancer Invest; 1986; 4(4):305-27. PubMed ID: 2429742
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum markers in small cell lung cancer: opportunities for improvement.
    Harmsma M; Schutte B; Ramaekers FC
    Biochim Biophys Acta; 2013 Dec; 1836(2):255-72. PubMed ID: 23796706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status of circulating protein biomarkers to aid the early detection of lung cancer.
    Hirales Casillas CE; Flores Fernández JM; Padilla Camberos E; Herrera López EJ; Leal Pacheco G; Martínez Velázquez M
    Future Oncol; 2014 Jun; 10(8):1501-13. PubMed ID: 25052758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunochemistry and lung cancer: application in diagnosis, prognosis and targeted therapy.
    Nanguzgambo AB; Razack R; Louw M; Bolliger CT
    Oncology; 2011; 80(3-4):247-56. PubMed ID: 21734416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic profiling of biofluids: potential in lung cancer screening and diagnosis.
    Duarte IF; Rocha CM; Gil AM
    Expert Rev Mol Diagn; 2013 Sep; 13(7):737-48. PubMed ID: 24063400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biological variables and stratification of patients with inoperable non-small-cell bronchial cancer: recommendations for future trials].
    Watine J; Friedberg B; Bouarioua N
    Cancer Radiother; 2002 Jun; 6(4):209-16. PubMed ID: 12224487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of pretherapeutic biomarkers in lung cancer with special regards to bronchoscopic procedures].
    Darwiche K; Özkan F; Ting S; Johnen G; Brüning T; Soltermann A; Huber LC; Christoph DC; Freitag L; Franzen D
    Pneumologie; 2014 Nov; 68(11):719-26. PubMed ID: 25003906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are There New Biomarkers in Tissue and Liquid Biopsies for the Early Detection of Non-Small Cell Lung Cancer?
    Calabrese F; Lunardi F; Pezzuto F; Fortarezza F; Vuljan SE; Marquette C; Hofman P
    J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30917582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.